• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Equillium Inc (NQ: EQ )

    0.7514 +0.0067 (+0.90%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Equillium Inc

    < Previous 1 2 3 4 5 6 Next >
    Equillium to Present at the H.C. Wainwright Virtual BioConnect Conference
    From Equillium, Inc.
    Via Business Wire
    10 Biggest Price Target Changes For Wednesday
    UBS cut the price target for Adobe Inc. (NASDAQ: ADBE) from $635 to $575. Adobe shares fell 2.3% to $541.06 in pre-market trading. SVB Leerink lowered the price target on... 
    Via Benzinga
    45 Biggest Movers From Yesterday
    Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced... 
    Via Benzinga
    Equillium Announces Publication of Data in the Journal of Clinical Investigation Highlighting the Importance of the CD6-ALCAM Pathway in the Pathogenesis of Lupus Nephritis
    From Equillium, Inc.
    Via Business Wire
    Equillium To Reassess Potential For Its Asthma Trials
    Equillium Inc's (NASDAQ: EQ) Phase 1b EQUIP study of itolizumab in patients with uncontrolled asthma met its primary objective. The data demonstrated an on-target... 
    Via Benzinga
    Equillium Announces Data from Phase 1b EQUIP Study in Patients with Uncontrolled Asthma
    From Equillium, Inc.
    Via Business Wire
    Equillium Announces Additional Patient Data at ASH 2021 Demonstrating Continued Positive and Durable Clinical Responses in Acute Graft-Versus-Host Disease Patients Treated with Itolizumab
    From Equillium, Inc.
    Via Business Wire
    Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates
    From Equillium, Inc.
    Via Business Wire
    Equillium to Present at Two Upcoming Investor Conferences
    From Equillium, Inc.
    Via Business Wire
    Equillium Presents Clinical Data from EQUALISE Phase 1b Study in Lupus Patients at the American Society of Nephrology Annual Meeting
    From Equillium, Inc.
    Via Business Wire
    Equillium Presents Interim Safety Data from First Cohort of Asthma Patients in Phase 1b EQUIP Study at the American College of Allergy, Asthma & Immunology Meeting
    From Equillium, Inc.
    Via Business Wire
    Equillium Announces Two Abstracts Accepted for Presentation at the 63rd ASH Annual Meeting and Exposition
    From Equillium, Inc.
    Via Business Wire
    Equillium Reveals Early Safety Data For Itolizumab In Lupus Patients
    Equillium Inc (NASDAQ: EQ) announced interim data from the Type A portion of the Phase 1b EQUALISE study in systemic lupus erythematosus (SLE) patients. Data were... 
    Via Benzinga
    Equillium Announces Interim Safety Data and Reduction in Proteinuria for Lupus Patients Treated with Itolizumab in the EQUALISE Study Presented at the ACR Annual Meeting
    From Equillium, Inc.
    Via Business Wire
    Equillium Announces Two Abstracts Accepted for Presentation at the Upcoming Virtual 2021 American Society of Nephrology Annual Meeting
    From Equillium, Inc.
    Via Business Wire
    Equillium Announces Multiple Abstracts Accepted for Presentation at ACR Convergence 2021
    From Equillium, Inc.
    Via Business Wire
    The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
    Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
    Via Benzinga
    Equillium to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
    From Equillium, Inc.
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021
    Upgrades For Alcoa Corp (NYSE: 
    Via Benzinga
    Equillium to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
    From Equillium, Inc.
    Via Business Wire
    60 Biggest Movers From Yesterday
    Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,... 
    Via Benzinga
    Equillium's Itolizumab Reduces Urine Protein In Lupus Patients
    Equillium Inc (NASDAQ: EQ) announced additional data from the Type A portion of the EQUALISE Phase 1b study of itolizumab in systemic lupus erythematosus (SLE) and... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers Hims & Hers Health (NYSE:HIMS)... 
    Via Benzinga
    Equillium Announces Update to EQUALISE Study of Itolizumab in Patients with Systemic Lupus Erythematosus and Lupus Nephritis
    From Equillium, Inc.
    Via Business Wire
    Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update
    From Equillium, Inc.
    Via Business Wire
    Equillium to Present at the BTIG Virtual Biotechnology Conference
    From Equillium, Inc.
    Via Business Wire
    Equillium's Single Phase 3 Study In aGVHD To Support US Filing Of Itolizumab
    Equillium Inc (NASDAQ: EQ) completed an End-of-Phase 1 meeting with the FDA, confirming to advance itolizumab into a single Phase 3 pivotal study in first-line... 
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    Exposures COVID-19
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers SCWorx (NASDAQ:WORX) shares rose... 
    Via Benzinga
    64 Biggest Movers From Friday
    Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained... 
    Via Benzinga
    Topics Initial Public Offering
    Exposures Securities Market
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.